However, the company's total income has increased by 10.1 per cent to Rs 470.46 crore, from last year's Q4 income of Rs 427.31 crore.
The company commands an over 80 per cent market share in the US generics market for Loratadine, according to its filing
The uptick in the Morepen Labs share came after the company announced that it has rolled out 'Empamore.'
Morepen Labs share price: Volumes on the Morepen Labs counter jumped suddenly around 1:05 PM with around 1.67 million shares changing hands in multiple tranches on the BSE